Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma
Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma |
|
https://doi.org/10.18632/oncotarget.26465
Kelly M. Bailey
|
| 37270-37271 |
Sequence variation in the microRNA region of a cancer virus
Sequence variation in the microRNA region of a cancer virus |
|
https://doi.org/10.18632/oncotarget.26471
Joseph M. Ziegelbauer
|
| 37272-37273 |
Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma
Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma |
|
https://doi.org/10.18632/oncotarget.26403
Javier Vaquero,
Cindy Lobe,
and Laura Fouassier
|
| 37274-37275 |
Battling quiescence for tumor eradication: too good to be true?
Battling quiescence for tumor eradication: too good to be true? |
|
https://doi.org/10.18632/oncotarget.26452
Nami McCarty
|
| 37276-37277 |
Revisiting entinostat as an immune-potentiating adjuvant
Revisiting entinostat as an immune-potentiating adjuvant |
|
https://doi.org/10.18632/oncotarget.26453
Tyler R. McCaw,
Troy D. Randall,
and Rebecca C. Arend
|
| 37278-37279 |
Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
|
https://doi.org/10.18632/oncotarget.26460
Toby A. Eyre
|
| 37280-37281 |
Exosomal transmission between macrophages and cancer cells: new insights to stroma-mediated drug resistance
Exosomal transmission between macrophages and cancer cells: new insights to stroma-mediated drug resistance |
|
https://doi.org/10.18632/oncotarget.26463
Ziv Gil
|
| 37282-37283 |
Reversing resistance to antiandrogens with a histone deacetylase inhibitor
Reversing resistance to antiandrogens with a histone deacetylase inhibitor |
|
https://doi.org/10.18632/oncotarget.26464
Anna C. Ferrari
|
| 37284-37285 |
Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins
Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins |
|
https://doi.org/10.18632/oncotarget.26466
Yves Pommier,
Mark Cushman,
and James H. Doroshow
|
| 37286-37288 |
Cell-surface GPNMB and induction of stemness
Cell-surface GPNMB and induction of stemness |
|
https://doi.org/10.18632/oncotarget.26472
Yukari Okita,
Chen Chen,
and Mitsuyasu Kato
|
| 37289-37290 |
Phosphorylated Akt1 expression is associated with poor prognosis in cutaneous, oral and sinonasal melanomas
Phosphorylated Akt1 expression is associated with poor prognosis in cutaneous, oral and sinonasal melanomas |
|
https://doi.org/10.18632/oncotarget.26458
Ciro Soares,
Thayná Melo de Lima Morais,
Roman Carlos,
Fernanda Viviane Mariano,
Albina Altemani,
Maria Goretti Freire de Carvalho,
Marcelo Brum Corrêa,
Rodrigo Ribas Dias dos Reis,
Luciana Schultz Amorim,
Oslei Paes de Almeida,
and Jacks Jorge
|
| 37291-37304 |
Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer
Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer |
|
https://doi.org/10.18632/oncotarget.26468
Daphne Brisard,
Frank Eckerdt,
Lindsey A. Marsh,
Gavin T. Blyth,
Sarika Jain,
Massimo Cristofanilli,
Dai Horiuchi,
and Leonidas C. Platanias
|
| 37305-37318 |
Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment
Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment |
|
https://doi.org/10.18632/oncotarget.26470
Abdul Khalid Siraj,
Poyil Pratheeshkumar,
Sandeep Kumar Parvathareddy,
Sasidharan Padmaja Divya,
Fouad Al-Dayel,
Asma Tulbah,
Dahish Ajarim,
and Khawla S. Al-Kuraya
|
| 37319-37332 |
Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model
Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model |
|
https://doi.org/10.18632/oncotarget.26484
Thinzar M. Lwin,
Kentaro Miyake,
Takashi Murakami,
Jonathan C. DeLong,
Siamak Amirfakhri,
Filemoni Filemoni,
Sang Nam Yoon,
Paul J. Yazaki,
John E. Shivley,
Brian Datnow,
Bryan M. Clary,
Robert M. Hoffman,
and Michael Bouvet
|
| 37333-37342 |
Correction: Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation
Correction: Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation |
|
https://doi.org/10.18632/oncotarget.26504
Mengmeng Cheng,
Shurong Hu,
Zhengting Wang,
Yaofei Pei,
Rong Fan,
Xiqiang Liu,
Lei Wang,
Jie Zhou,
Sichang Zheng,
Tianyu Zhang,
Yun Lin,
Maochen Zhang,
Ran Tao,
and Jie Zhong
|
| 37343-37343 |
Correction: PreImplantation factor (PIF) protects cultured embryos against oxidative stress: relevance for recurrent pregnancy loss (RPL) therapy
Correction: PreImplantation factor (PIF) protects cultured embryos against oxidative stress: relevance for recurrent pregnancy loss (RPL) therapy |
|
https://doi.org/10.18632/oncotarget.26505
Lindsay F. Goodale,
Soren Hayrabedyan,
Krassimira Todorova,
Roumen Roussev,
Sivakumar Ramu,
Christopher Stamatkin,
Carolyn B. Coulam,
Eytan R. Barnea,
and Robert O. Gilbert
|
| 37344-37344 |
